[go: up one dir, main page]

MX9604483A - Derivados de benzamida, composiciones que contienen dicho derivado y uso de las mismas. - Google Patents

Derivados de benzamida, composiciones que contienen dicho derivado y uso de las mismas.

Info

Publication number
MX9604483A
MX9604483A MX9604483A MX9604483A MX9604483A MX 9604483 A MX9604483 A MX 9604483A MX 9604483 A MX9604483 A MX 9604483A MX 9604483 A MX9604483 A MX 9604483A MX 9604483 A MX9604483 A MX 9604483A
Authority
MX
Mexico
Prior art keywords
derivative
compositions containing
benzamide
compound
symbols
Prior art date
Application number
MX9604483A
Other languages
English (en)
Other versions
MXPA96004483A (es
Inventor
Jean-Francois Rossignol
Original Assignee
Jean-Francois Rossignol
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/301,407 external-priority patent/US5578621A/en
Application filed by Jean-Francois Rossignol filed Critical Jean-Francois Rossignol
Priority claimed from PCT/EP1995/001334 external-priority patent/WO1995028393A1/en
Publication of MXPA96004483A publication Critical patent/MXPA96004483A/es
Publication of MX9604483A publication Critical patent/MX9604483A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La presente invencion se refiere a un nuevo compuesto de la formula I, con uno de los símbolos R1, R2, R3, R4 y R5 que representan OH, mientras que los símbolos restantes representan H; a una composicion farmacéutica que contiene el mencionado compuesto, y al uso de dicho compuesto como agente antiparasitario, antibacteriano, antimicotico y antiviral.
MX9604483A 1994-09-08 1995-04-11 Derivados de benzamida, composiciones que contienen dicho derivado y uso de las mismas. MX9604483A (es)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US08227033 1994-04-13
US08301407 1994-09-08
US08/301,407 US5578621A (en) 1994-09-08 1994-09-08 Benzamide derivatives
US38385595A 1995-02-06 1995-02-06
US383855 1995-02-06
US383,855 1995-02-06
PCT/EP1995/001334 WO1995028393A1 (en) 1994-04-13 1995-04-11 Benzamide derivative, compositions containing said derivative and use thereof

Publications (2)

Publication Number Publication Date
MXPA96004483A MXPA96004483A (es) 1998-02-01
MX9604483A true MX9604483A (es) 1998-02-28

Family

ID=26972350

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9604483A MX9604483A (es) 1994-09-08 1995-04-11 Derivados de benzamida, composiciones que contienen dicho derivado y uso de las mismas.

Country Status (2)

Country Link
US (2) US5886013A (es)
MX (1) MX9604483A (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6653318B1 (en) 1999-07-21 2003-11-25 Yale University 5-(E)-Bromovinyl uracil analogues and related pyrimidine nucleosides as anti-viral agents and methods of use
US7125568B2 (en) * 2001-08-23 2006-10-24 Sung Michael T Lipophilic drug compositions
CA2467321A1 (en) * 2004-05-14 2005-11-14 Paul J. Santerre Polymeric coupling agents and pharmaceutically-active polymers made therefrom
UA90864C2 (en) 2004-09-09 2010-06-10 Ромарк Лебораториз, Л.К. Halogenated benzamide derivatives
US20060194853A1 (en) * 2004-10-08 2006-08-31 Rossignol Jean F Alkyl benzamides
EP2047850A3 (en) * 2005-04-12 2009-07-29 Romark Laboratories, L.C. Methods for treating diseases through inhibition of the function of molecular chaperones such as protein disulfide isomerases , pharmaceutical compositions comprising them, and screening methods for identifying therapeutic agents
UA100840C2 (ru) * 2006-01-09 2013-02-11 РОМАРК ЛЕБОРЕТЕРИЗ, Эл.Си. Композиция для лечения вирусного гепатита
EA019357B1 (ru) 2007-08-03 2014-03-31 Ромарк Лабораториз Л.С. Алкилсульфонилзамещённые n-(тиазол-2-ил)бензамиды и их применение для лечения вирусной инфекции гепатита c
US8524278B2 (en) 2009-02-13 2013-09-03 Romark Laboratories L.C. Controlled release pharmaceutical formulations of nitazoxanide
EA021587B1 (ru) * 2009-05-12 2015-07-30 РОМАРК ЛЭБОРЕТЕРИЗ Эл. Си. Соединения галогеналкилгетероарилбензамида
CN108042535A (zh) 2009-06-26 2018-05-18 罗马克实验室有限公司 用于治疗流感的化合物和方法
KR102037162B1 (ko) 2011-05-16 2019-10-29 로마크 레버러토리즈, 엘.씨. 바이러스병, 암 및 세포내 감염으로 인한 질병의 예방 및 치료를 위한 티아졸리드 화합물의 용도
WO2016077420A1 (en) 2014-11-11 2016-05-19 Romark Laboratories, L.C. Compositions and methods of treatment with prodrugs of tizoxanide, an analogue or salt thereof
EA202091849A1 (ru) 2016-03-31 2020-12-11 Ромарк Лабораториз Л.С. Тиазолидные соединения для лечения вирусных инфекций
PT3777855T (pt) 2016-04-11 2023-01-10 Genfit Métodos de tratamento para doenças fibróticas
WO2018195035A1 (en) 2017-04-18 2018-10-25 Romark Laboratories L.C. Inhibition of protein disulfide-isomerase a3
WO2019148293A1 (en) 2018-02-02 2019-08-08 Interface Biologics, Inc. Glass formulations comprising steroid dimers and uses thereof
WO2021220061A2 (en) 2020-05-01 2021-11-04 Ripple Therapeutics Corporation Heterodimer compositions and methods for the treatment of ocular disorders
WO2022020243A1 (en) 2020-07-20 2022-01-27 Romark Laboratories L.C. Crystalline salts of tizoxanide and 2-hydroxy-n-(5-chloro-1,3-thiazol-2-yl)benzamide (rm-4848) with ethanolamine, morpholine, propanolamine, piperazine and n-methylpiperazine
CA3189487A1 (en) 2020-08-24 2023-03-03 Jean-Francois Rossignol Use of thiazolides against coronaviruses

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2132431A (en) * 1934-04-27 1938-10-11 O'brien Brian Irradiating method and apparatus
FR1306603A (fr) * 1958-08-14 1962-10-19 Innothera Lab Sa Dérivés thiazoliques et leur procédé de préparation
FR716M (es) * 1960-08-05 1961-08-07
DE2132431A1 (de) * 1971-06-30 1973-01-11 Riedel De Haen Ag 4-phenyl-thiazolderivate enthaltende pharmazeutische praeparate
GB1437800A (en) * 1973-08-08 1976-06-03 Phavic Sprl Derivatives of 2-benzamido-5-nitro-thiazoles
FR2435905A1 (fr) * 1978-09-13 1980-04-11 Anvar Nouveaux agents molluscicides derives du benzamido-2 nitro-5 thiazole
US4315018A (en) * 1978-12-07 1982-02-09 Rossignol Jean F Specific parasiticidal use of 2-benzamido-5-nitro-thiazole derivatives
US4962117A (en) * 1987-11-25 1990-10-09 Merck Frosst Canada, Inc. Heterazole dialkanoic acids
FR2677356B1 (fr) * 1991-06-05 1995-03-17 Sanofi Sa Derives heterocycliques d'acylamino-2 thiazoles-5 substitues, leur preparation et compositions pharmaceutiques en contenant.

Also Published As

Publication number Publication date
US5886013A (en) 1999-03-23
US6020353A (en) 2000-02-01

Similar Documents

Publication Publication Date Title
MX9604483A (es) Derivados de benzamida, composiciones que contienen dicho derivado y uso de las mismas.
BG100884A (en) Benzamide derivative, compositions containing said derivative and use thereof
BR9713925A (pt) Composto, processo para preparação de um composto, e, composição farmacêutica
CA2425560A1 (en) Anticholinergics, processes for preparing them and their use as pharmaceutical compositions
MY116845A (en) New 19-nor-pregnene derivatives
NL350075I2 (es)
AP9701039A0 (en) Derivatives of 2- (2-oxo-ethlidene)-imidazolidin-4-one.
MX9604020A (es) Arilalquildiazinonas.
CZ142195A3 (en) Injectable composition containing derivatives of taxan group
IL99775A0 (en) Antimicrobial agents containing substituted 2-cyclohexan-1-yl-amino derivatives,certain such novel compounds and their preparation
GEP20022824B (en) Antipicornaviral Compounds, Pharmaceutical Compositions Containing the Same and Methods for Treatment
GB9408185D0 (en) New benzamide derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same
IL114833A0 (en) Anthracyclinone derivatives their preparation and pharmaceutical compositions containing them
IL140070A0 (en) Benzamide derivatives and pharmaceutical compositions containing the same
ATE240331T1 (de) Azatricyclo(3.3.1.1)decanderivate und diese enthaltende phrmazeutische zubereitungen
HU9601587D0 (en) Antracycline derivatives
IL99898A0 (en) 7-acyl-3-substituted carbamoyloxy cephem compounds,their preparation and antibacterial compositions containing them
PL314794A1 (en) Crystalline polymorphous form of (s,s,s)-n-(1-[2-carbocy-3-(n2-mezilolysilamino)propyl]-1-cyclopentylocabonyl)thyrosine
IL150100A0 (en) Pharmaceutical compositions containing fused cyclic compounds
IL114646A (en) Pharmaceutical compositions containing phenylurea derivatives for inhibiting leukotriene biosynthesis
GEP20002095B (en) Antracycline Disaccharides, Process for Their Preparation and Pharmaceutical Compositions
WO2002040005A3 (en) Blockade of sodium channels by phenol derivatives
TWI256383B (en) Anthraquinone compound
UA41309C2 (uk) ПОХІДНІ 11-<font face="Symbol">b</font>-БЕНЗАЛЬДОКСИМЕСТРА-4,9-ДІЄНУ, СПОСІБ ЇХ ОТРИМАННЯ ТА ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ